StonvexLoading…
StonvexStonvexStonvexCore line items from MNY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $79.51M | $80.67M | $68.13M | $61.88M |
Operating Income | $-40.19M | $-30.03M | $-40.97M | $-29.23M |
Net Income | $-37.79M | $-172.60M | $-49.44M | $-30.93M |
EPS (Diluted) | $-0.94 | $-17.92 | $-102.43 | $-143.21 |
Total Assets | Not available | Not available | Not available | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $42.52M | $68.64M | $24.08M | $9.19M |
Free Cash Flow OCF − CapEx | $-25.23M | $-17.16M | $-14.86M | $-14.67M |
Shares Outstanding | 43.63M | 42.00M | 6.21M | 815.70K |